logo

VetSRev

Translational Intracerebral Hemorrhage Research: Has Current Neuroprotection Research ARRIVEd at a Standard for Experimental Design and Reporting?

Liddle, L. J. and Ralhan, S. and Ward, D. L. and Colbourne, F.

Transl Stroke Res (2020) 11: 1203–1213

DOI: 10.1007/s12975-020-00824-x

Abstract

One major aim of preclinical intracerebral hemorrhage (ICH) research is to develop and test potential neuroprotectants. Published guidelines for experimental design and reporting stress the importance of clearly and completely reporting results and methodological details to ensure reproducibility and maximize information availability. The current review has two objectives: first, to characterize current ICH neuroprotection research and, second, to analyze aspects of translational design in preclinical ICH studies. Translational design is the adoption and reporting of experimental design characteristics that are thought to be clinically relevant and critical to reproducibility in animal studies (e.g., conducting and reporting experiments according to the STAIR and ARRIVE guidelines, respectively). Given that ICH has no current neuroprotective treatments and an ongoing reproducibility crisis in preclinical research, translational design should be considered by investigators. We conducted a systematic review of ICH research from 2015 to 2019 using the PubMed database. Our search returned 281 published manuscripts studying putative neuroprotectants in animal models. Contemporary ICH research predominantly uses young, healthy male rodents. The collagenase model is the most commonly used. Reporting of group sizes, blinding, and randomization are almost unanimous, but group size calculations, mortality and exclusion criteria, and animal model characteristics are infrequently reported. Overall, current ICH neuroprotection research somewhat aligns with experimental design and reporting guidelines. However, there are areas for improvement. Because failure to consider translational design is associated with inflation of effect sizes (and possibly hindered reproducibility), we suggest that researchers, editors, and publishers collaboratively consider enhanced adherence to published guidelines.

Citation

Liddle, L. J., Ralhan, S., Ward, D. L., & Colbourne, F. (2020). Translational Intracerebral Hemorrhage Research: Has Current Neuroprotection Research ARRIVEd at a Standard for Experimental Design and Reporting? Transl Stroke Res, 11(6), 1203–1213. https://doi.org/10.1007/s12975-020-00824-x Animals, Humans, *Neuroprotection, *Translational research, *Systematic review, *Disease Models, Animal, Neuroprotective Agents/*pharmacology, Cerebral Hemorrhage/*drug therapy, *Animal models, Research Design/*standards, *Experimental design, *Experimental reporting, *Intracerebral hemorrhage, *Reproducibility, Translational Medical Research/*standards

Keywords